Abstract
THE SEQUELAE of choroidal neovascularization (CNV) are important causes of visual morbidity. Age-related macular degeneration (AMD) is the leading cause of visual loss in older Americans. Approximately 90% of blindness secondary to AMD is related to the neovascular type of AMD. Neovascular complications of the ocular histoplasmosis syndrome (OHS) can be an important cause of blindness in younger Americans, especially if untreated. Laser treatment, as demonstrated in clinical trials by the Macular Photocoagulation Study (MPS) Group, shows a very strong treatment benefit with respect to decreasing the risk of severe visual acuity loss in patients with extrafoveal or juxtafoveal CNV complicating AMD 1,2 or OHS, 3,4 as well as in patients with new (no prior treatment) subfoveal or recurrent subfoveal CNV complicating AMD. 5,6 Patients can expect to preserve good visual acuity (20/40 or better) following laser treatment in more than 85% of extrafoveal cases secondary to OHS. However, virtually
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
